Allianz's Buyback Nears the Finish Line as Berenberg Backs a 684-Euro Recovery
Published on 09/29/2026 at 21:11 | Editorial boerse-global.de
Allianz shares are drifting lower while the Munich insurer's share-repurchase programme winds toward its close, leaving investors to weigh a strikingly bullish broker target against a growing pile of strategic questions. The stock changed hands at 425.80 euros on Tuesday, down 0.4%, and sits 6.3% below its 52-week high — a pullback of roughly 6.0% since the buyback was flagged as all but finished about two weeks ago.
That softness has done little to shake Berenberg's conviction. Analyst Michael Huttner reaffirmed his buy rating and a 684-euro price target, framing the recent consolidation as an opening rather than a warning sign. His case rests on the earnings power of the DAX heavyweight and the wide gap between the current quote and his projection.
The 141-Billion-Euro Question Mark
Central to the bull thesis is how resilient Allianz's alternative investments really are. Roughly 141 billion euros sit in non-listed assets, and sceptics worry that valuation risk lurks inside that book — the kind that could force write-downs if market pressure persists. Berenberg dismisses those fears as overdone, arguing that balance-sheet quality and the income generated by the private holdings will determine whether investor confidence snaps back quickly or valuation discounts cap the upside for months.
Capital returns have been running in the meantime. Between 21 and 22 September 2026, the group bought back a further 182,616 of its own shares, lifting the cumulative total since the programme began on 13 March 2026 to 6,247,961. An earlier tranche saw 122,659 shares repurchased between 14 and 18 September, taking the running tally to 6,065,345 at that point.
Should investors sell immediately? Or is it worth buying Allianz?
Barclays Digs In on the Bear Side
Not everyone is cheering. Claudia Gaspari of Barclays nudged her target up to 353 euros from 350 on 4 September 2026 — a marginal tweak that left her sell recommendation untouched. Her concern is a lack of earnings momentum, paired with a valuation that, in her view, already reflects the group's current profit potential. Should earnings growth flatten out over the coming quarters, the room for multiple expansion would narrow further.
Then there is the wildcard of M&A. Allianz is reported to be among a small group of suitors for AA Ltd, the British roadside-assistance provider, with a price tag of about 5.8 billion euros — equivalent to five billion pounds. Private equity firm EQT is also in the running, and no deal has come together yet. Allianz has stayed silent on the talks with advisers to current owners Towerbrook Capital Partners and Warburg Pincus, leaving both the status and the outcome up in the air. A multi-billion acquisition of that scale would test the group's capital discipline and could raise doubts about future distribution capacity.
What to Watch Into November
Clear markers now frame the path ahead. If the shares hold their footing and the anxiety over the 141-billion-euro unlisted portfolio proves unfounded, the recovery scenario Berenberg favours stays firmly in play — potentially putting the 52-week high of 454.50 euros back in reach. Should sentiment sour and Barclays' doubts about earnings momentum take hold, a fresh test of lower support levels becomes the risk.
The next hard catalyst is already circled: Allianz publishes its third-quarter 2026 interim statement on 12 November 2026. Until those figures land, fresh detail on strategic initiatives and the direction of interest rates will be the forces tilting the balance between optimists and sceptics.
Ad
Allianz Stock: New Analysis - 29 September
Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
